Dmytro Shymkiv said that Darnitsa has successfully completed a number of studies of important medicines in EU laboratories
During the period from 2018 to 2020, the Ukrainian pharmaceutical company "Darnitsa" completed 8 studies of generics - bioequivalent drugs ...
